|
LOSS PER COMMON SHARE - Schedule of Anti-Delutive Effect (Details)
|
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
|
Sep. 30, 2012
|
Sep. 30, 2011
|
Sep. 30, 2012
|
Sep. 30, 2011
|
|
| Earnings Per Share [Abstract] | ||||
| Warrants | 3,811,119 | 2,492,861 | 3,811,119 | 2,492,861 |
| Stock options | 1,840,556 | 787,778 | 1,840,556 | 787,778 |
| Convertible notes | 2,304,478 | 1,438,497 | 2,304,478 | 1,438,497 |
| Series A Preferred | 1,292,492 | 1,396,742 | 1,292,492 | 1,396,742 |
| Series B Preferred | 2,993,504 | 3,051,884 | 2,993,504 | 3,051,884 |
| Series C Preferred | 451,750 | 451,750 | 451,750 | 451,750 |
| [PotentialCommonShares] | 12,693,899 | 9,619,512 | 12,693,899 | 9,619,512 |